(Q36637072)

English

Botulinum toxin: a potential alternative to current treatment of neurogenic and idiopathic urinary incontinence due to detrusor overactivity

scientific article published on 27 October 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

1 reference

Europe PubMed Central

Botulinum toxin: a potential alternative to current treatment of neurogenic and idiopathic urinary incontinence due to detrusor overactivity (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

urinary incontinence

1 reference

based on heuristic

inferred from title

author name string

N Casanova

1

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

E McGuire

2

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

D E Fenner

3

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

publication date

27 October 2006

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

International Journal of Gynecology and Obstetrics

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

95

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

305-311

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Injectable neuromodulatory agents: botulinum toxin therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2006.08.014

21 January 2018

European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2006.08.014

21 January 2018

The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2006.08.014

21 January 2018

Botulinum toxin type A injections for treating neurogenic detrusor overactivity combined with low-compliance bladder in patients with spinal cord lesions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2006.08.014

21 January 2018

Efficacy of botulinum-A toxin in the treatment of detrusor overactivity incontinence: a prospective nonrandomized study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2006.08.014

21 January 2018

A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2006.08.014

21 January 2018

Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2006.08.014

21 January 2018

Botulinum toxin type B injection for management of type A resistant neurogenic detrusor overactivity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2006.08.014

21 January 2018

Identifiers

10.1016/J.IJGO.2006.08.014

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36637072&oldid=1642513971"